欢迎访问西域试剂网!

请登录 | 免费注册

rel-α-Vitamin E rel-D-α-Tocopherol,70.0%

产品编号:Bellancom-N0683A| CAS NO:2074-53-5| 分子式:C29H50O2| 分子量:430.71

rel-α-Vitamin E (rel-(+)-α-Tocopherol) 是一种具有抗氧化特性的维生素,也是一种混合物。

本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的,不可用于人类或动物的临床诊断或者治疗,非药用,非食用,

货号 包装 价格 库存与货期 购买量 操作
Bellancom-N0683A
600.00 杭州 北京(现货)

增值税发票√顺丰快递√订货电话:18601927057

rel-α-Vitamin E rel-D-α-Tocopherol

产品介绍 rel-α-Vitamin E (rel-D-α-Tocopherol) 是一种具有抗氧化特性的维生素,也是一种混合物。
生物活性

rel-α-Vitamin E (rel-D-α-Tocopherol) is a vitamin with antioxidant properties and also a mixture.

体外研究

Vitamin E is a lipid-soluble, chain-breaking type of antioxidant present in human blood. Vitamin E works as a free radical scavenger and has the primary function of destroying peroxyl radicals. Thus, it protects long-chain polyunsaturated fatty acids (e.g., cell membranes or low-density lipoprotein cholesterol) from oxidation or destruction. Its association with vitamin C is of great pathophysiological importance, because inhibition of lipid peroxidation by α-tocopherol occurs through its conversion into an oxidized α-tocopheroxyl radical, which in turn is regenerated to α-tocopherol through reduction by redox-active reagents.
α-Tocopherol can inhibit the recruitment of lymphocytes and eosinophils.

西域 has not independently confirmed the accuracy of these methods. They are for reference only.

体内研究

In order to longitudinally relate vitamin E status, evaluated by means of α- and γ-tocopherol measured in erythrocytes membranes, to inflammatory state and oxidative stress by means of total antioxidant capacity of plasma and lipid peroxidation biomarkers, and to assess its association to hard long-term outcomes (e.g., overall and cause-specific graft and recipient loss), and to be able to likewise account for liver, lung, and heart transplant recipients.

西域 has not independently confirmed the accuracy of these methods. They are for reference only.

体内研究

In order to longitudinally relate vitamin E status, evaluated by means of α- and γ-tocopherol measured in erythrocytes membranes, to inflammatory state and oxidative stress by means of total antioxidant capacity of plasma and lipid peroxidation biomarkers, and to assess its association to hard long-term outcomes (e.g., overall and cause-specific graft and recipient loss), and to be able to likewise account for liver, lung, and heart transplant recipients.

西域 has not independently confirmed the accuracy of these methods. They are for reference only.

性状Oil
溶解性数据
In Vitro: 

Ethanol : 50 mg/mL (116.09 mM; Need ultrasonic)

DMSO : 16.11 mg/mL (37.40 mM; Need ultrasonic)

H2O : < 0.1 mg/mL (insoluble)

配制储备液
浓度 溶剂体积 质量 1 mg 5 mg 10 mg
1 mM 2.3217 mL 11.6087 mL 23.2175 mL
5 mM 0.4643 mL 2.3217 mL 4.6435 mL
10 mM 0.2322 mL 1.1609 mL 2.3217 mL
*

请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效
储备液的保存方式和期限:-80°C, 6 months; -20°C, 1 month。-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。

In Vivo:

请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照 In Vitro 方式配制澄清的储备液,再依次添加助溶剂:

——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用; 以下溶剂前显示的百
分比是指该溶剂在您配制终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶

  • 1.

    请依序添加每种溶剂: 10% DMSO    40% PEG300    5% Tween-80    45% saline

    Solubility: ≥ 1.61 mg/mL (3.74 mM); Clear solution

    此方案可获得 ≥ 1.61 mg/mL (3.74 mM,饱和度未知) 的澄清溶液。

    以 1 mL 工作液为例,取 100 μL 16.1 mg/mL 的澄清 DMSO 储备液加到 400 μL PEG300 中,混合均匀;向上述体系中加入50 μL Tween-80,混合均匀;然后继续加入 450 μL生理盐水定容至 1 mL。

    将 0.9 g 氯化钠,完全溶解于 100 mL ddH₂O 中,得到澄清透明的生理盐水溶液
  • 2.

    请依序添加每种溶剂: 10% DMSO    90% corn oil

    Solubility: ≥ 1.61 mg/mL (3.74 mM); Clear solution

    此方案可获得 ≥ 1.61 mg/mL (3.74 mM,饱和度未知) 的澄清溶液,此方案不适用于实验周期在半个月以上的实验。

    以 1 mL 工作液为例,取 100 μL 16.1 mg/mL 的澄清 DMSO 储备液加到 900 μL玉米油中,混合均匀。

*以上所有助溶剂都可在 西域 网站选购。
运输条件

Room temperature in continental US; may vary elsewhere.

储存方式
Pure form -20°C 3 years
4°C 2 years
In solvent -80°C 6 months
-20°C 1 month
参考文献

相关文档

化学品安全说明书(MSDS)

下载MSDS

质检证书(COA)

相关产品


服务热线

13911702513
18601927057

微信客服